The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus

BACKGROUND: Guidelines classify sacubitril/valsartan as a significant part of medical treatment of heart failure with reduced ejection fraction (HFrEF). Data have shown that the HbA1c levels in patients with diabetes mellitus could be impacted by sacubitril/valsartan. A possible positive effect in d...

Descripción completa

Detalles Bibliográficos
Autores principales: El‐Battrawy, Ibrahim, Demmer, Jonathan, Abumayyaleh, Mohammad, Crack, Carina, Pilsinger, Christina, Zhou, Xiaobo, Mügge, Andreas, Akin, Ibrahim, Aweimer, Assem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053359/
https://www.ncbi.nlm.nih.gov/pubmed/36479630
http://dx.doi.org/10.1002/ehf2.14239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053359/
https://www.ncbi.nlm.nih.gov/pubmed/36479630
http://dx.doi.org/10.1002/ehf2.14239

Ejemplares similares